• Twitter()
  • Facebook()
  • Print this Story
  • Email this Story
Text Size AAA

New INVO Program: NewCures

Modified: December 18, 2017

Northwestern is proud to launch NewCures, a university biomedical accelerator that will focus on advancing the development of potential therapeutics. NewCures is an INVO initiative, supported by the Office for Research, that aims to capture the value of new innovations from Evanston and Chicago laboratories, and ultimately to strengthen Northwestern’s therapeutic pipeline.

NewCures Mission

  • To accelerate development and translation of biomedical projects to a decision point
  • To mentor NU’s biomedical leaders to advance their research to commercialization opportunities
  • To strengthen NU’s therapeutics pipeline to ultimately benefit the public

The Request for Applications was released on December 4. Applications will need to be submitted by Northwestern principal investigators (PIs) with a full-time faculty appointments. Interested postdoctoral fellows should speak with their PI in order to submit an application. Applications are due by January 15!

For more information, visit the NewCures webpage here. You may also contact NewCures directly with any general inquiries.

Funding Connection